Status:
COMPLETED
Adjunctive Study of AL-37807 Ophthalmic Suspension
Lead Sponsor:
Alcon Research
Conditions:
Open-Angle Glaucoma
Ocular Hypertension
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of the study is to compare the safety and intraocular pressure-lowering efficacy of AL-37807 ophthalmic suspension vs. Timolol gel forming solution vs. AL-37807 vehicle, all dosed concomit...
Eligibility Criteria
Inclusion
- Open-angle glaucoma
- Ocular hypertension
- Must have been on Xalatan for at least 3 months
- VA not worse than 0.60
- Other protocol-defined inclusion criteria may apply
Exclusion
- Age related
- Other protocol-defined exclusion criteria may apply
Key Trial Info
Start Date :
November 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2008
Estimated Enrollment :
129 Patients enrolled
Trial Details
Trial ID
NCT00620256
Start Date
November 1 2007
End Date
July 1 2008
Last Update
December 5 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Contact Alcon Call Center at 1-888-451-3937
Fort Worth, Texas, United States, 76134